Strainprint™ Technologies Ltd., Gynica & Lumir Lab to release custom questionnaire to select eligible participants for world-leading medical cannabis research TORONTO, Aug. 7, 2019 /PRNewswire/ -

EMERYVILLE, Calif., Aug. 7, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader in digital cell biology, today announced the appointment of

PHILADELPHIA, Aug. 7, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338 for adult onset Still's disease (AOSD),

CAMBRIDGE, Mass., Aug. 7, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for avapritinib for the treatment of adult patients

ISFIYA, Israel, Aug. 7, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only preparation-free ingestible capsule

KFAR SABA, Israel, Aug. 7, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the successful enrollment and operation of the first two patients in the Agili-C™ Investigational Device Exemption (IDE) pivotal study at Hospital for Special Surgery (HSS), New York, NY

FT. LAUDERDALE, Fla., Aug. 7, 2019 /PRNewswire/ -- According to a new study by Weatherby Healthcare, nearly two-thirds of actively practicing physicians are still carrying

SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced financial results for the second quarter and six months ended June 30, 2019 and provided a corporate update.

LAS VEGAS, Aug. 7, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyund

BOSTON, Aug. 7, 2019 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ("Blue Cross") announced today that